Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

J Neurochem. 1992 Feb;58(2):786-9. doi: 10.1111/j.1471-4159.1992.tb09789.x.

Abstract

Incubation of 10 mM 1-methyl-4-phenylpyridinium (MPP+) with sonicated beef heart mitochondria caused an irreversible time-dependent decrease in NADH-ubiquinone-1 (CoQ1) reductase activity (52% inhibition after 1 h). Inclusion of glutathione, ascorbate, or catalase in the incubation mixture protected the NADH-CoQ1 reductase activity. These results suggest that the interaction of MPP+ with complex I induces free radical generation, which in turn leads to the irreversible inhibition of complex I activity. The generation of free radicals by neurotoxin-induced inhibition of complex I has important implications for our interpretation of the increased oxidative stress observed in Parkinson's disease substantia nigra and for our understanding of the cause(s) of dopaminergic cell death in this disorder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / pharmacology*
  • Animals
  • Ascorbic Acid / pharmacology
  • Catalase / pharmacology
  • Cattle
  • Free Radicals
  • Glutathione / pharmacology
  • Mitochondria / metabolism*
  • NAD(P)H Dehydrogenase (Quinone) / antagonists & inhibitors*
  • Osmolar Concentration

Substances

  • Free Radicals
  • Catalase
  • NAD(P)H Dehydrogenase (Quinone)
  • Glutathione
  • Ascorbic Acid
  • 1-Methyl-4-phenylpyridinium